Fred Schwarzer | President and Chief Executive Officer |
Misbah Tahir | Chief Financial Officer |
Bruce Keyt | Chief Scientific Officer |
Daniel Chen | Chief Medical Officer |
Stephen Willey | Stifel, Nicolaus & Company, Inc. |
Michael Schmidt | Guggenheim Securities, LLC |
Brian Abrahams | RBC Capital Markets |
Asthika Goonewardene | Truist Securities, Inc. |
Good day, everyone, and welcome to the IGM Biosciences Fourth Quarter and Full-Year 2020 Financial Results Call. Today's call is being recorded. At this time, I would like to turn the call over to Misbah Tahir, Chief Financial Officer of IGM.
Thank you, operator. Welcome, and thank you to those of you joining us today to discuss IGM's fourth quarter and full-year 2020 financial results.